New generation vaccines /

Saved in:
Bibliographic Details
Edition:3rd ed, rev. and expanded.
Imprint:New York : Marcel Dekker, 2004.
Description:xiii, 1117 p. : ill. ; 29 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/5127906
Hidden Bibliographic Details
Other authors / contributors:Levine, Myron M. (Myron Max), 1944-
ISBN:0824740718 : No price
Notes:Includes bibliographical references and index.
Table of Contents:
  • Foreword / Gustav J. V. Nossal
  • 1. Vaccines and Vaccination in Historical Perspective / Myron M. Levine and Rosanna Lagos
  • 2. An Overview of Biotechnology in Vaccine Development / James B. Kaper and Rino Rappuoli
  • 3. Initial Clinical Evaluation of New Vaccine Candidates: Investigators' Perspective of Phase I and II Clinical Trials of Safety, Immunogenicity, and Preliminary Efficacy / Carol O. Tacket, Karen L. Kotloff and Margaret B. Rennels
  • 4. Long-Term Evaluation of Vaccine Protection: Methodological Issues for Phase III and IV Studies / John D. Clemens, Abdollah Naficy, Malla R. Rao and Hye-won Koo
  • 5. Ethical Considerations in the Conduct of Vaccine Trials in Developing Countries / Charles Weijer and Claudio F. Lanata
  • 6. Vaccine Economics: From Candidates to Commercialized Products in the Developing World / Amie Batson, Piers Whitehead and Sarah Glass
  • 7. Development and Supply of Vaccines: An Industry Perspective / Michel Greco
  • 8. Reaching Every Child - Achieving Equity in Global Immunization / R. Bruce Aylward, M. Birmingham, J. Lloyd and B. Melgaard
  • 9. A Paradigm for International Cooperation: The Global Alliance for Vaccines and Immunization (GAVI) and the Vaccine Fund / Lisa Jacobs, Jacques-Francois Martin and Tore Godal
  • 10. Economic Analyses of Vaccines and Vaccination Programs / Benjamin Schwartz and Ismael Ortega-Sanchez
  • 11. The Role of the Food and Drug Administration in Vaccine Testing and Licensure / Norman Baylor, Lydia A. Falk and Karen Midthun
  • 12. Developing Safe Vaccines / Leslie K. Ball, Robert Ball and Bruce G. Gellin
  • 13. Polio Eradication: Capturing the Full Potential of a Vaccine / R. Bruce Aylward, Rudolph Tangermann, Roland Sutter and Stephen L. Cochi
  • 14. Recent Advances in Immunology that Impact Vaccine Development / Marcelo B. Sztein
  • 15. High-Throughout Informatics and In Vitro Assays for T-Cell Epitope Determination: Application to the Design of Epitope-Driven Vaccines / Anne S. DeGroot, Hakima Sbai, William Martin, John Sidney, Alessandro Sette and Jay A. Berzofsky
  • 16. The Challenge of Inducing Protection in Very Young Infants / Claire-Anne Siegrist
  • 17. Vaccination and Autoimmunity / Paul-Henri Lambert and Michel Goldman
  • 18. Adjuvants for the Future / Richard T. Kenney and Robert Edelman
  • 19. MF59 Adjuvant Emulsion / Audino Podda and Giuseppe Del Giudice
  • 20. Immune-Enhancing Sequences (CpG Motifs), Cytokines, and Other Immunomodulatory Moieties / Sanjay Gurunathan, Dennis M. Klinman and Robert A. Seder
  • 21. Use of Genetically Detoxified Mutants of Cholera and Escherichia coli Heat-Labile Enterotoxins as Mucosal Adjuvants / Gordon Dougan and Gill Douce
  • 22. Recent Developments in Vaccine Delivery Systems / Derek T. O'Hagan
  • 23. Proteosome Technology for Vaccines and Adjuvants / George H. Lowell, David Burt, Greg White and Louis Fries
  • 24. Viruslike Particle (VLP) Vaccines / Margaret E. Conner and Mary K. Estes
  • 25. Immunostimulating Reconstituted Influenza Virosomes / Reinhard Glueck
  • 26. Plants as a Production and Delivery Vehicle for Orally Delivered Subunit Vaccines / Tsafrir S. Mor, Hugh S. Mason, Dwayne D. Kirk, Charles J. Arntzen and Guy A. Cardineau
  • 27. Vaccinia Virus and Other Poxviruses as Live Vectors / Bernard Moss
  • 28. Live Adenovirus Recombinants as Vaccine Vectors / L. Jean Patterson, Bo Peng, Xinli Nan and Marjorie Robert-Guroff
  • 29. RNA Virus Replicon Vaccines / Nancy L. Davis and Robert E. Johnston
  • 30. Attenuated Salmonella and Shigella as Live Vectors Carrying Either Prokaryotic or Eukaryotic Expression Systems / James E. Galen, Marcela F. Pasetti, Marcelo B. Sztein, Eileen M. Barry and Myron M. Levine
  • 31. DNA Vaccines / Indresh K. Srivastava, Margaret A. Liu and Jeffrey B. Ulmer
  • 32. DNA-Modified Virus Ankara and Other Heterologous Prime-Boost Immunization Strategies for Effector T Cell Induction / Adrian V. S. Hill, Joerg Schneider and Andrew J. McMichael
  • 33. Mucosal Immunization and Needle-Free Injection Devices / Myron M. Levine and James D. Campbell
  • 34. Transcutaneous Immunization / Gregory M. Glenn and Richard T. Kenney
  • 35. Combination Vaccines for Routine Infant Immunization / Margaret B. Rennels, Rosanna M. Lagos and Kathryn M. Edwards
  • 36. Meningococcal Conjugate and Protein-Based Vaccines / Rino Rappuoli, Andrew J. Pollard and E. Richard Moxon
  • 37. The Postlicensure Impact of Haemophilus influenzae Type b and Serogroup C Neisseria meningitides Conjugate Vaccines / Jay Wenger, Helen Campbell, Elizabeth Miller and David Salisbury
  • 38. Pneumococcal Protein-Polysaccharide Conjugate Vaccines / Orin S. Levine, David L. Klein and Jay C. Butler
  • 39. Pneumococcal Common Proteins and Other Vaccine Strategies / David E. Briles, James C. Paton and Susan K. Hollingshead
  • 40. Polysaccharide-Based Conjugate Vaccines for Enteric Bacterial Infections: Typhoid Fever, Nontyphoidal Salmonellosis, Shigellosis, Cholera, and Escherichia coli 0157 / Shousun C. Szu, John B. Robbins, Rachel Schneerson, Vince Pozsgay and Chiayung Chu
  • 41. Attenuated Strains of Salmonella enterica serovar Typhi as Live Oral Vaccines Against Typhoid Fever / Myron M. Levine, James Galen, Carol O. Tacket, Eileen M. Barry, Marcela F. Pasetti and Marcelo B. Sztein
  • 42. Vaccines Against Lyme Disease / Mark S. Hanson and Robert Edelman
  • 43. Oral B Subunit-Killed Whole-Cell Cholera Vaccine / Jan Holmgren and Charlotta Bergquist
  • 44. Attenuated Vibrio cholerae Strains as Live Oral Cholera Vaccines and Vectors / James B. Kaper and Carol O. Tacket
  • 45. Novel Vaccines Against Tuberculosis / Robert J. Wilkinson and Douglas B. Young
  • 46. New Approaches to Influenza Vaccine / John J. Treanor, James C. King and Kenneth M. Zangwill
  • 47. Chimeric Vaccines Against Japanese Encephalitis, Dengue, and West Nile / Konstantin V. Pugachev, Thomas P. Monath and Farshad Guirakhoo
  • 48. Challenges and Current Strategies in the Development of HIV/AIDS Vaccines / Chad A. Womack, Margaret A. Liu and Barney S. Graham
  • 49. Vaccine Strategies to Prevent Dengue Fever / Niranjan Kanesa-thasan, J. Robert Putnak and David W. Vaughn
  • 50. Vaccination Against the Hepatitis C Viruses / Michael Houghton and Sergio Abrignani
  • 51. Live Vaccine Strategies to Prevent Rotavirus Disease / Richard L. Ward, H. Fred Clark, Paul A. Offit and Roger I. Glass
  • 52. Vaccines Against Respiratory Syncytial Virus and Parainfluenza Virus Types 1-3 / James E. Crowe, Jr., Peter L. Collins and Brian R. Murphy
  • 53. Developing a Vaccine Against Epstein-Barr Virus / Denis Moss and Mandvi Bharadwaj
  • 54. Cytomegalovirus Vaccines / David I. Bernstein and Stanley A. Plotkin
  • 55. Herpes Simplex Vaccines / Richard J. Whitley
  • 56. Vaccines for Hantaviruses, Lassa Virus, and Filoviruses / Connie Schmaljohn, Joseph B. McCormick, Gary J. Nabel and Alan Schmaljohn
  • 57. Development of a Vaccine to Prevent Infection with Group A Streptococci and Rheumatic Fever / Michael F. Good, P. J. Cleary, James Dale, Vincent Fischetti, K. Fuchs, H. Sabharwal and J. Zabriskie
  • 58. Vaccines Against Group B Streptococcus / Morven S. Edwards, Lawrence C. Paoletti and Carol J. Baker
  • 59. Overview of Live Vaccine Strategies Against Shigella / Karen L. Kotloff, Thomas L. Hale, Eileen M. Barry and Philippe Sansonetti
  • 60. Oral Inactivated Whole Cell B Subunit Combination Vaccine Against Enterotoxigenic Escherichia coli / Ann-Mari L. Svennerholm and Stephen J. Savarino
  • 61. Multivalent Shigella/Enterotoxigenic Escherichia coli Vaccine / Eileen M. Barry and Myron M. Levine
  • 62. Vaccines Against Gonococcal Infection / Timothy A. Mietzner, Christopher E. Thomas, Marcia M. Hobbs and Myron S. Cohen
  • 63. Vaccines Against Campylobacter jejuni / David R. Tribble, Shahida Baqar and Daniel A. Scott
  • 64. Vaccines Against Uropathogenic Escherichia coli / Solomon Langermann and W. Ripley Ballou, Jr.
  • 65. Vaccine Strategies Against Helicobacter pylori / Karen L. Kotloff, Cynthia K. Lee and Giuseppe Del Giudice
  • 66. Vaccines for Staphylococcus aureus Infections / Ali I. Fattom, Gary Horwith and Robert Naso
  • 67. Moraxella catarrhalis and Nontypable Haemophilus influenzae Vaccines to Prevent Otitis Media / Philippe A. Denoel, Fabrice Godfroid, Joelle Thonnard, Cecile Neyt, David W. Dyer and Jan T. Poolman
  • 68. Vaccines for Chlamydia trachomatis and Chlamydia pneumoniae / Andrew D. Murdin and Robert C. Brunham
  • 69. Overview of Vaccine Strategies for Malaria / Michael F. Good and David Kemp
  • 70. Adjuvanted RTS,S and Other Protein-Based Pre-Erythrocytic Stage Malaria Vaccines / D. Gray Heppner, Jr., James F. Cummings, Joe D. Cohen, W. Ripley Ballou, Jr., Christian F. Ockenhouse and Kent E. Kester
  • 71. Malaria: A Complex Disease that May Require A Complex Vaccine / Stephen L. Hoffman, Denise L. Doolan and Thomas L. Richie
  • 72. Plasmodium falciparum Asexual Blood Stage Vaccine Candidates: Current Status / Danielle I. Stanisic, Laura B. Martin, Robin F. Anders and Michael F. Good
  • 73. Malaria Transmission-Blocking Vaccines / Allan Saul
  • 74. Vaccines Against Leishmania / Farrokh Modabber, Steven G. Reed and Antonio Campos-Neto
  • 75. Vaccines Against Schistosomiasis / Andre Capron, Gilles J. Riveau, Paul B. Bartley and Donald P. McManus
  • 76. Vaccines Against Entamoeba histolytica / Christopher D. Huston and William A. Petri, Jr.
  • 77. Vaccines Against Human Hookworm Disease / Peter J. Hotez, Zhan Bin, Alex Loukas, Jeff M. Bethony, James Ashcom, Kashinath Ghosh, John M. Hawdon, Walter Brandt and Philip K. Russell
  • 78. Principles of Therapeutic Vaccination for Viral and Nonviral Maligancies / Drew M. Pardoll
  • 79. Vaccines Against Human Papillomavirus Infection / John Boslego, Xiaosong Liu and Ian H. Frazer
  • 80. Active Immunization with Dendritic Cells Bearing Melanoma Antigens / Ralph M. Steinman, Karolina Palucka, Jacques Banchereau, Beatrice Schuler-Thurner and Gerold Schuler
  • 81. Vaccine Against Alzheimer's Disease / Roy M. Robins-Browne, Richard A. Strugnell and Colin L. Masters
  • 82. Vaccines Against Atherosclerosis / Carl R. Alving
  • 83. Vaccine Therapy / Donald S. Burke
  • 84. Vaccination-Based Therapies in Multiple Sclerosis / Jacqueline Shukaliak-Quandt and Roland Martin
  • 85. Vaccine Therapy for Autoimmune Diabetes / Irun R. Cohen
  • 86. Vaccines for the Treatment of Autoimmune Diseases / David C. Wraith
  • 87. Vaccines to Treat Drug Addiction / Paul R. Pentel and Dan E. Keyler
  • 88. Vaccines Against Agents of Bioterrorism / Theodore J. Cieslak, Mark G. Kortepeter and Edward M. Eitzen, Jr.
  • 89. A Primer on Large-Scale Manufacture of Modern Vaccines / Julie B. Milstien, Jean Stephenne and Lance Gordon
  • 90. Heterogeneity of Pediatric Immunization Schedules in Industrialized Countries / James D. Campbell and Margaret Burgess.